The Safety and Efficacy of Adalimumab in Patients with Crohn's Disease: The Experience of a Single Tertiary Care Center

被引：0
|
作者：
Teriaky, Anouar [1 ]
Mosli, Mahmoud [1 ]
Gregor, Jamie [1 ]
Yan, Brian [1 ]
Ponich, Terry [1 ]
Chande, Nilesh [1 ]
机构：
[1] Univ Western Ontario, London, ON, Canada
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2013年 / 108卷
关键词：
D O I：
10.14309/00000434-201310001-01701
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1701
引用
收藏
页码：S512 / S512
页数：1
相关论文
共 50 条
  • [41] Perianal Crohn's disease - Experience of a tertiary referral center
    Fernandes, S.
    Sousa, P.
    Moura, M.
    Correia, L.
    Goncalves, A. Rita
    Santos, P. Moura
    Valente, A.
    Baldaia, C.
    Velosa, J.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S230 - S230
  • [42] Efficacy and Safety of Escalation of Adalimumab Therapy to Weekly Dosing in Pediatric Patients with Crohn's Disease
    Dubinsky, Marla C.
    Rosh, Joel
    Faubion, William A.
    Kierkus, Jaroslaw
    Ruemmele, Frank
    Hyams, Jeffrey S.
    Eichner, Samantha
    Li, Yao
    Huang, Bidan
    Mostafa, Nael M.
    Lazar, Andreas
    Thakkar, Roopal B.
    INFLAMMATORY BOWEL DISEASES, 2016, 22 (04) : 886 - 893
  • [43] Efficacy, Safety, and Demographics Factor of Adalimumab Therapy in 1693 Japanese Crohn's Disease Patients
    Ogata, Haruhiko
    Watanabe, Mamoru
    Matsui, Toshiyuki
    Abe, Sadanori
    Haruna, Shigenori
    Hibi, Toshifumi
    GASTROENTEROLOGY, 2014, 146 (05) : S461 - S461
  • [44] SHORT-TERM EFFICACY AND SAFETY OF ADALIMUMAB IN CHILDREN WITH ACTIVE CROHN'S DISEASE: A PROSPECTIVE, OPEN LABEL, SINGLE CENTER TRIAL
    Viola, F.
    Civitelli, F.
    Romeo, E.
    Nuti, F.
    Aloi, M.
    Maiella, G.
    Labalestra, V.
    Borrelli, O.
    Cucchiara, S.
    DIGESTIVE AND LIVER DISEASE, 2008, 40 : S68 - S68
  • [45] Short-term efficacy and safety of adalimumab in children with active Crohn's disease: A prospective, open label, single center trial
    Viola, Franca
    Civitelli, Fortunata
    Romeo, Erminia
    Maiella, Giulia
    Nuti, Federica
    Aloi, Marina
    Borrelli, Osvaldo
    Cucchiara, Salvatore
    GASTROENTEROLOGY, 2008, 134 (04) : A664 - A664
  • [46] Efficacy and safety of adalimumab in Canadian patients with moderate to severe Crohn's disease: Results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn's DiseaSe (ACCESS) trial
    Panaccione, Remo
    Loftus, Edward V., Jr.
    Binion, David
    McHugh, Kevin
    Alam, Shamsul
    Chen, Naijun
    Guerette, Benoit
    Mulani, Parvez
    Chao, Jingdong
    CANADIAN JOURNAL OF GASTROENTEROLOGY, 2011, 25 (08): : 419 - 425
  • [47] Crohn's disease outcome in patients under azathioprine: A tertiary referral center experience
    Magro, Fernando
    Santos-Antunes, Joao
    Vilas-Boas, Filipe
    Rodrigues-Pinto, Eduardo
    Coelho, Rosa
    Ribeiro, Orquidea Silva
    Lopes, Susana
    Macedo, Guilherme
    JOURNAL OF CROHNS & COLITIS, 2014, 8 (07): : 617 - 625
  • [48] Crohn's disease outcome in patients under azathioprine: a tertiary referral center experience
    Santos-Antunes, J.
    Magro, F.
    Vilas-Boas, F.
    Rodrigues-Pinto, E.
    Coelho, R.
    Ribeiro, O.
    Lopes, S.
    Macedo, G.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S287 - S287
  • [49] Adalimumab efficacy and safety by disease duration: analysis of pooled studies of Crohn's disease
    Panaccione, R.
    Rutgeerts, P.
    Sandborn, W.
    Schreiber, S.
    Colombel, J. -F.
    Berg, S.
    Maa, J. -F.
    Petersson, J.
    Robinson, A. M.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S271 - S271
  • [50] ADALIMUMAB EFFICACY AND SAFETY BY DISEASE DURATION: ANALYSIS OF POOLED STUDIES OF CROHN'S DISEASE
    Panaccione, Remo
    Rutgeerts, Paul
    Sandborn, William J.
    Schreiber, Stefan
    Colombel, Jean Frederic
    Berg, Sofie
    Maa, Jen-Fue
    Petersson, Joel H.
    Robinson, Anne M.
    GASTROENTEROLOGY, 2017, 152 (05) : S744 - S744
12345